COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1515: Articles 15141-15150  | Next

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials
Roman, Y. M., Burela, P. A., Pasupuleti, V., Piscoya, A., Vidal, J. E., Hernandez, A. V.
10.1101/2021.05.21.21257595 — Posted: 2021-05-25 Discussion: Onsite | Offsite
SARS-CoV-2 spike protein unlikely to bind to integrins via the Arg-Gly-Asp (RGD) motif of the Receptor Binding Domain: evidence from structural analysis and microscale accelerated molecular dynamics
Othman, H., Ben Messaoud, H., Khamessi, O., Ben Mabrouk, H., Ghedira, K., Bharuthram, A., Treurnicht, F., Achilonu, I., Sayed, Y., Srairi-Abid, N.
10.1101/2021.05.24.445335 — Posted: 2021-05-24
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
Khan, W. H., Khan, N., Mishra, A., Gupta, S., Bansode, V., Mehta, D., Bhambure, R., Rathore, A. S.
10.1101/2021.05.23.445305 — Posted: 2021-05-24
Genome-wide identification and prediction of SARS-CoV-2 mutations show an abundance of variants: Integrated study of bioinformatics and deep neural learning.
Hossain, M. S., Pathan, A. Q. M. S. U., Islam, M. N., Tonmoy, M. I. Q., Rakib, M. I., Munim, M. A., Saha, O., Fariha, A., Al Reza, H., Roy, M., Bahadur, N. M., Rahaman, M. M.
10.1101/2021.05.23.445341 — Posted: 2021-05-24
Investigating the possible origin and transmission routes of SARS-CoV-2 genomes and variants of concern in Bangladesh
Nahid, A. A., Ghosh, A.
10.1101/2021.05.24.444482 — Posted: 2021-05-24
Severe Acute Respiratory Syndrome Coronavirus-2 genome sequence variations relate to morbidity and mortality in Coronavirus Disease-19
Mehta, P., Sarkar, S., Ghoshal, U., Pandey, A., Singh, R., Singh, D., Vishvkarma, R., Ghoshal, U. C., Maurya, R., Pandey, R., Ramachandran, R., Bhadury, P., Kundu, T. K., Singh, R.
10.1101/2021.05.24.445374 — Posted: 2021-05-24
Nucleocapsid mutation R203K/G204R increases the infectivity, fitness and virulence of SARS-CoV-2
Wu, H., Xing, N., Meng, K., Fu, B., Xue, W., Dong, P., Xiao, Y., Liu, G., Luo, H., Zhu, W., Lin, X., Meng, G., Zhu, Z.
10.1101/2021.05.24.445386 — Posted: 2021-05-24
Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model
Yadav, P., Mohandas, S., Sarkale, P., Nyayanit, D., Shete, A., Sahay, R., Potdar, V., Baradkar, S., Gupta, N., Sapkal, G., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.05.24.445424 — Posted: 2021-05-24
Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core
Pak, A. J., Yu, A., Ke, Z., Briggs, J., Voth, G. A.
10.1101/2021.05.24.445443 — Posted: 2021-05-24
Evidence for Deleterious Original Antigenic Sin in SARS-CoV-2 Immune Response
Sen, S. R., Sanders, E. C., Santos, A. M., Bhuvan, K., Tang, D. Y., Gelston, A. A., Miller, B. M., Ricks-Oddie, J. L., Weiss, G. A.
10.1101/2021.05.21.445201 — Posted: 2021-05-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).